Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discuss the role of autologous stem cell transplant (ASCT) for multiple myeloma during the IMWG Conference Series filmed at ASH 2017 in Atlanta, Georgia.

click here to download slides

We thank our supporters of this program:
Abbvie, AMGEN, Bristol-Myers Squibb Celgene Corporation, Janssen Oncology, Takeda Oncology


Previous Post
ASH17: Frontline Options
Next Post
ASH 17: Maintenance Recommendations

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.